Fox Chase's Mark Morgan Selected As "Top Doc" by Women's Health Magazine
The gynecologic oncology surgeon was one of only five physicians from the Northeast selected for the list.
PHILADELPHIA (Nov. 3, 2008) — Women's Health magazine has named Mark A. Morgan, MD, FACOG, FACS, chief of gynecologic surgical oncology at Fox Chase Cancer Center, as a "Top Doc" – one of only five oncologists chosen for the list from the Northeast.
Morgan's specialty is complex gynecologic surgery and the surgical management of gynecologic malignancies, including ovarian, uterine, vulvar and cervical cancers. He has special training and vast experience in laparoscopic and robotic surgery. In addition, Morgan performs fertility-sparing surgery for early cervical cancer, as well as providing surgical treatment for urinary and rectal fistulas.
"Combining state-of-the-art surgery with innovative new therapies in a cancer center that emphasizes compassionate, personal care, gives my patients the best chance for survival and quality of life," Morgan says.
Morgan received his undergraduate degree from Rutgers College and his MD in 1982 from the State University of New York Downstate Medical Center, where he was elected to the medical honor society Alpha Omega Alpha. He also received the Merck Company Award for General Excellence. He completed his residency in obstetrics and gynecology and a fellowship in gynecologic oncology at the Hospital of the University of Pennsylvania. Prior to joining Fox Chase, he was a professor in the division of gynecologic oncology at the University of Pennsylvania Health System where he founded the division of urogynecology and female reconstructive pelvic surgery.
Morgan has given many invited lectures throughout the world and published numerous research papers and book chapters. He also travels regularly to Africa on surgical missions to treat women with obstetric fistulas.
Women's Health magazine "was created for the woman who sees being healthy – physically and emotionally – as her edge." The magazine's stated circulation is 1.1 million.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy Moore at 215-728-2700.